van Waarde A - Search Results

1

Quantifying drug-related 5-HT1A receptor occupancy with.

Passchier J, van Waarde A, Pieterman RM, Willemsen AT, Vaalburg W. Passchier J, et al. Among authors: van waarde a. Psychopharmacology (Berl). 2001 May;155(2):193-7. doi: 10.1007/s002130100688. Psychopharmacology (Berl). 2001. PMID: 11401009

2

Suitability of CGP-12177 and CGP-26505 for quantitative imaging of beta-adrenoceptors.

van Waarde A, Meeder JG, Blanksma PK, Bouwer J, Visser GM, Elsinga PH, Paans AM, Vaalburg W, Lie KI. van Waarde A, et al. Int J Rad Appl Instrum B. 1992 Oct;19(7):711-8. doi: 10.1016/0883-2897(92)90130-q. Int J Rad Appl Instrum B. 1992. PMID: 1356953

3

Uptake of radioligands by rat heart and lung in vivo: CGP 12177 does and CGP 26505 does not reflect binding to beta-adrenoceptors.

Van Waarde A, Meeder JG, Blanksma PK, Brodde OE, Visser GM, Elsinga PH, Paans AM, Vaalburg W, Lie KI. Van Waarde A, et al. Eur J Pharmacol. 1992 Nov 3;222(1):107-12. doi: 10.1016/0014-2999(92)90469-k. Eur J Pharmacol. 1992. PMID: 1361437

4

Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate.

Pruim J, Willemsen AT, Molenaar WM, van Waarde A, Paans AM, Heesters MA, Go KG, Visser GM, Franssen EJ, Vaalburg W. Pruim J, et al. Among authors: van waarde a. Radiology. 1995 Oct;197(1):221-6. doi: 10.1148/radiology.197.1.7568827. Radiology. 1995. PMID: 7568827

5

Myocardial and pulmonary uptake of S-1'-[18F]fluorocarazolol in intact rats reflects radioligand binding to beta-adrenoceptors.

Van Waarde A, Elsinga PH, Brodde OE, Visser GM, Vaalburg W. Van Waarde A, et al. Eur J Pharmacol. 1995 Jan 16;272(2-3):159-68. doi: 10.1016/0014-2999(94)00636-l. Eur J Pharmacol. 1995. PMID: 7713160

6

Quantification of an 11C-labelled beta-adrenoceptor ligand, S-(-)CGP 12177, in plasma of humans and rats.

van Waarde A, Anthonio RL, Visser TJ, Elsinga PH, Posthumus H, Weemaes AM, Blanksma PK, Visser GM, Paans AM, Vaalburg W. van Waarde A, et al. J Chromatogr B Biomed Appl. 1995 Jan 20;663(2):361-9. doi: 10.1016/0378-4347(94)00442-8. J Chromatogr B Biomed Appl. 1995. PMID: 7735484 Clinical Trial.

7

In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET.

Willemsen AT, van Waarde A, Paans AM, Pruim J, Luurtsema G, Go KG, Vaalburg W. Willemsen AT, et al. Among authors: van waarde a. J Nucl Med. 1995 Mar;36(3):411-9. J Nucl Med. 1995. PMID: 7884503 Free article.

8

Synthesis and evaluation of 1'-[18F]fluorometoprolol as a potential tracer for the visualization of beta-adrenoceptors with PET.

de Groot TJ, van Waarde A, Elsinga PH, Visser GM, Brodde OE, Vaalburg W. de Groot TJ, et al. Among authors: van waarde a. Nucl Med Biol. 1993 Jul;20(5):637-42. doi: 10.1016/0969-8051(93)90033-q. Nucl Med Biol. 1993. PMID: 8395276

9

Quantification of the beta-adrenoceptor ligand S-1'-[18F]fluorocarazolol in plasma of humans, rats and sheep.

van Waarde A, Visser TJ, Posthumus H, Elsinga PH, Anthonio RL, van Loenen-Weemaes AM, Visser GM, Beaufort-Krol GC, Paans AM, Vaalburg W. van Waarde A, et al. Among authors: van loenen weemaes am. J Chromatogr B Biomed Appl. 1996 Apr 12;678(2):253-60. doi: 10.1016/0378-4347(95)00472-6. J Chromatogr B Biomed Appl. 1996. PMID: 8738029

10

In vitro evaluation of N-(fluoro)isopropyl norephedrine as potential cardiac imaging agents for PET.

de Groot TJ, Buitenhuis CK, Rutgers M, van Waarde A, Visser GM, Smets LA, Brodde OE, Vaalburg W. de Groot TJ, et al. Among authors: van waarde a. Nucl Med Biol. 1996 Feb;23(2):155-7. doi: 10.1016/0969-8051(95)02048-9. Nucl Med Biol. 1996. PMID: 8868288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page